| 國立成功大學 |
2014-02-10 |
(KPI) 建置國際化比較基因體學研究中心
|
嚴元宏 |
| 國家衛生研究院 |
2014-03 |
KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan
|
Chen, YT;Lin, JC;Fung, CP;Lu, PL;Chuang, YC;Wu, TL;Siu, LK |
| 國家衛生研究院 |
2012-04 |
KPC-2-producing sequence type 11 Klebsiella pneumoniae detected in Taiwan
|
Lauderdale, TL;Shi, ZY;Lin, CF;Lai, JF;Tan, MJ;Wang, JT;Chang, SC |
| 臺大學術典藏 |
2020-12-30T02:42:53Z |
KPC-2-producing sequence type 11 Klebsiella pneumoniae detected in Taiwan
|
Lauderdale T.-L.; Shi Z.-Y.; Lin C.-F.; Lai J.-F.; Tan M.-C.; Wang J.-T.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2022-05-13T08:04:50Z |
KPC-2-producing sequence type 11 Klebsiella pneumoniae detected in Taiwan
|
Lauderdale T.-L.; Shi Z.-Y.; Lin C.-F.; Lai J.-F.; Tan M.-C.; JANN-TAY WANG; Chang S.-C. |
| 國立臺灣大學 |
2012 |
KPC-2-Producing Sequence Type 11 Klebsiella pneumoniae Detected in Taiwan\
|
Lauderdale, Tsai-Ling; Shi, Zhi-Yuan; Lin, Chin-Fu; Lai, Jui-Fen; Tan, Mei-Chen; Wang, Jan-Tay; Chang, Shan-Chwen; 張上淳; 王振泰 |
| 國立臺灣大學 |
2012 |
KPC-2-Producing Sequence Type 11 Klebsiella pneumoniae Detected in Taiwan\
|
Lauderdale, Tsai-Ling; Shi, Zhi-Yuan; Lin, Chin-Fu; Lai, Jui-Fen; Tan, Mei-Chen; Wang, Jan-Tay; Chang, Shan-Chwen; 張上淳; 王振泰 |
| 國立臺灣大學 |
2005 |
KPCA和KFD的屬性解釋以及分類法則之研究
|
陳宜鴻; Chen, Yi-Hung |
| 國立政治大學 |
2014-08 |
KPIs in Taiwan basic education.
|
陳榮政; Wu, Ching Shan; Chen, Robin Jung-Cheng |
| 樹德科技大學 |
2007 |
KPI績效評估制度之公平知覺、工作動機與工作績效之關聯性探討
|
陳仕傑; CHEN SHIH CHIEN |
| 中國文化大學 |
2012 |
KPI考核制度、獎勵制度與工作滿意度之相關研究-以科技產業研發人員為例
|
郭金城 |
| 國立成功大學 |
2023-08-15 |
KPT plus plus : Refined knowledgeable prompt tuning for few-shot text classification
|
Ni;Shiwen;Kao;Hung-Yu |
| 國立成功大學 |
2023 |
KPT++: Refined knowledgeable prompt tuning for few-shot text classification
|
Ni, S.;Kao, H.-Y. |
| 中國文化大學 |
2017-08-01 |
KP加影像回饋對於桌球動作技能表現之影響
|
陳慶帆; 簡崇霖 |
| 淡江大學 |
2017-08 |
KP加影像回饋對於桌球動作技能表現之影響
|
陳慶帆(Chen, Ching-fan) ； 簡崇霖(Chien Chung-lin) |
| 國立虎尾科技大學 |
2015 |
KP升壓型轉換器之30瓦LED驅動器之研製
|
李倉期 |
| 臺北醫學大學 |
2012 |
Kr?ppel-Like Factor 10 Expression as a Prognostic Indicator for Pancreatic Adenocarcinoma
|
VHS, Chang;Chu, PY;Peng, SL;Mao, TL;Shan, YS;Hsu, CF;Lin, CY;KKC, Tsai;WCY, Yu;Ch'ang, HJ |
| 臺大學術典藏 |
2020-03-05T12:32:51Z |
Kr?ppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma
|
Chang V.H.S.; Chu P.-Y.; Peng S.-L.; TSUI-LIEN MAO; Shan Y.-S.; Hsu C.-F.; Lin C.-Y.; Tsai K.K.C.; Yu W.C.Y.; Ch'Ang H.-J. |
| 臺北醫學大學 |
2012 |
Kr?ppel-like factor 10 upregulates the expression of cyclooxygenase 1 and further modulates angiogenesis in endothelial cell and platelet aggregation in gene-deficient mice
|
Diane, H.A.Yang;Hsu, Ching-Fang;Lin, Chun-Yu;Guo, Jia-Yi;Winston, C.Y.Yu;Vincent, H.S.Chang |
| 亞洲大學 |
2007-04 |
Kr?ppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion
|
Xianhui Wang;Mingzhe Zheng;Gang Liu;Weiya Xia;Paula J. Mckeown-Longo;Mien-Chie Hung;Jihe Zhao |
| 臺大學術典藏 |
2020-02-17T07:43:40Z |
Kr?ppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells
|
Wong C.-W; Hou P.-S; Tseng S.-F; Chien C.-L; Wu K.-J; Chen H.-F; HONG-NERNG HO; Kyo S; Teng S.-C. |
| 臺大學術典藏 |
2022-04-15T03:14:26Z |
Kr?ppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells
|
Huang Y.-C.; Chen H.-T.; SHU-CHUN TENG |
| 淡江大學 |
2005-06 |
Krachschlagen: Versuch �ber Elfriede Jelineks Prosa
|
狄殷豪 |
| 國立臺灣科技大學 |
2018 |
Kraft lignin biorefinery: A perspective
|
Hu, J.;Zhang, Q.;Lee, D.-J. |
| 國立臺灣科技大學 |
2018 |
Kraft lignin biorefinery: A perspective
|
Hu, J.;Zhang, Q.;Lee, D.-J. |
| 嘉南藥理大學 |
2009 |
Krankenhaus-Hygiene + Infektionsverh�
|
Elsevier SDOL |
| 國立臺灣大學 |
2015 |
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation
|
Serrano, Cesar; Wang, Yuexiang; Marino-Enriquez, Adrian; Lee, Jen-Chieh; Ravegnini, Gloria; Morgan, Jeffrey A.; Bertagnolli, Monica M.; Beadling, Carol; Demetri, George D.; Corless, Christopher L.; Heinrich, Michael C.; Fletcher, Jonathan A.; 李仁傑 |
| 臺大學術典藏 |
2018-09-10T15:28:15Z |
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation
|
Serrano, C. and Wang, Y. and Mari\\~no-Enr\\'iquez, A. and Lee, J.-C. and Ravegnini, G. and Morgan, J.A. and Bertagnolli, M.M. and Beadling, C. and Demetri, G.D. and Corless, C.L. and Heinrich, M.C. and Fletcher, J.A.; JEN-CHIEH LEE |
| 臺大學術典藏 |
2020-03-07T06:52:12Z |
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation
|
Serrano C.;Wang Y.;Mariño-Enríquez A;Jen-Chieh Lee;Ravegnini G.;Morgan J.A.;Bertagnolli M.M.;Beadling C.;Demetri G.D.;Corless C.L.;Heinrich M.C.;Fletcher J.A.; Serrano C.; Wang Y.; Mariño-Enríquez A.; JEN-CHIEH LEE; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A. |
| 臺大學術典藏 |
2015 |
KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation
|
Serrano C.; Wang Y.; Mari?o-Enr?quez A.; JEN-CHIEH LEE; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A. |
| 國立成功大學 |
2017-07-26 |
KRAS Gene Mutations在大腸直腸癌肝轉移中扮演的角色
|
林鵬展; Lin, Peng-Chan |
| 臺大學術典藏 |
2012 |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 國立臺灣大學 |
2012 |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin, Yu-Lin; Liau, Jau-Yu; Yu, Shan-Chi; Ou, Da-Liang; Lin, Liang-In; Tseng, Li-Hui; Chang, Yih-Leong; Yeh, Kun-Huei; Cheng, Ann-Lii; 林亮音; 曾麗慧; 張逸良; 林育麟; 鄭安理; 葉坤輝; 歐大諒; 尤善琦; 廖肇裕 |
| 臺大學術典藏 |
2018-09-10T09:22:43Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Ou, Da-Liang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Ou, D.-L. and Lin, L.-I. and Tseng, L.-H. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; Lin, Yu-Lin; LI-HUI TSENG; Lin, Yu-Lin; Liau, Jau-Yu; YIH-LEONG CHANG; JAU-YU LIAU; Yu, Shan-Chi; Ou, Da-Liang; DA-LIANG OU; Ou, Da-Liang; LIANG-IN LIN; Lin, Liang-In; Lin, Liang-In; Tseng, Li-Hui; KUN-HUEI YEH; Tseng, Li-Hui; Chang, Yih-Leong; YU-LIN LIN; Yeh, Kun-Huei; ANN-LII CHENG; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Cheng, Ann-Lii |
| 臺大學術典藏 |
2012 |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Yeh K.-H.; Cheng A.-L.; YIH-LEONG CHANG; Lin L.-I.; Tseng L.-H.; Yu S.-C.; Ou D.-L.; Liau J.-Y.; Lin Y.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Liau J.-Y.; SHAN-CHI YU; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L. |
| 臺大學術典藏 |
2020-03-07T06:56:33Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:39Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:53:55Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-03-10T07:58:45Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Ou D.-L.; Lin L.-I.; LI-HUI TSENG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 國家衛生研究院 |
2013-05 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, LT;Chen, JS;Chao, Y;Tsai, CS;Shan, YS;Hsu, C;Huang, SF;Tsou, HH;Lee, KD;Chiu, CF;Rau, KM;Ho, CL;Yu, MS;Taiwan Cooperative Oncology Group |
| 國立成功大學 |
2013-05-20 |
KRAS mutation status-stratified randomized phase II trial of GEMOX with and without cetuximab in advanced biliary tract cancer (ABTC): The TCOG T1210 trial
|
Chen, Li-Tzong; Chen, Jen-Shi; Chao, Yee; Tsai, Chang-Sung; Shan, Yan-Shen; Hsu, Chiun; Huang, Shiu-Feng; Tsou, Hsiao-Hui; Lee, Kuan-Der; Chiu, Chang-Fang; Rau, Kun-Ming; Ho, Ching-Liang; Yu, Ming-Sun |
| 國立臺灣大學 |
2014 |
KRAS 基因突變增加oxaliplatin化學治療藥物敏感性對轉移性結腸直腸癌的生物意義與臨床影響
|
林育麟; Lin, Yu-Lin |
| 亞洲大學 |
1999 |
Krashen 之第二語言習得理論及其對台灣國小英語教學之啟示
|
張湘君 |
| 國立臺灣師範大學 |
2014-10-27T15:12:35Z |
Krashen's Five Hypotheses and their Implications
|
張進生 |
| 國立臺灣師範大學 |
2014-10-27T15:13:44Z |
Krashen's Five Hypotheses and Their Implications
|
張進生 |
| 國立臺灣師範大學 |
2014-10-27T15:13:44Z |
Krashen's Five Hypotheses and Their Implications
|
張進生 |
| 國立臺灣師範大學 |
2014-10-27T15:12:35Z |
Krashen's Five Hypotheses and their Implications
|
張進生 |
| 高雄醫學大學 |
2015 |
Kras和 p53在子宮內膜異位相關卵巢肉瘤癌老鼠中所扮演的角色
|
林筱芸; Lin, Hsiao-Yun |
| 高雄醫學大學 |
2010 |
KRAS啟動子對於MAZ與PARP-1的反應為GA-element四倍體形式存在的關鍵
|
Cogoi;S;Paramasivam;M;Membrino;A;橫山一成, ;Xodo;L.E. ; Cogoi;S;Paramasivam;M;Membrino;A;Yokoyama;K.K;Xodo, and;L.E. |
